Malignant Brain Tumors Recruiting Phase 2 Trials for Cabozantinib (DB08875)

Also known as: Malignant Brain Tumor

IndicationStatusPhase
DBCOND0050591 (Malignant Brain Tumors)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02885324Pilot Study of Cabozantinib for Recurrent or Progressive High-Grade Glioma in ChildrenTreatment